Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence
International Journal of Drug Delivery Technology · 14.03.2026 · 16 (7s)
DOI: 10.25258/ijddt.16.7s.22 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.03.2026. Verfasst von Sai Meera S und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Aspirin is widely studied for its anticancer effects, such as immune response regulation, reduced platelet activation, and cyclooxygenase (COX) inhibition. However, concerns remain about its potential to promote cancer in certain scenarios and the risk of serious bleeding events. Aim and Objective: This systematic review aims to analyze long-term aspirin effects on cancer incidence, progression, mortality, and associated hazards, including bleeding and potential tumor growth in the elderly. Materials and Methods: The association between aspirin usage, adverse events, and cancer outcomes was established by analyzing data from significant randomized controlled trials, cohort studies, and mechanistic investigations, such as the Lancet, CAPP2, ASPREE, and Women's Health Study trials.
Result
Long-term aspirin usage had a moderate protective effect against ovarian cancer and considerably decreased the incidence and death of colorectal cancer. According to mechanistic research, aspirin may stop metastases by boosting T-cell-mediated immunity and blocking platelet-derived thromboxane A₂ (TXA₂). Findings in older groups, however, is variable; some research suggested no mortality benefit and even a potential rise in late-stage cancer deaths. Significant bleeding in the brain and gastrointestinal tract continued to be significant side effects, especially in older patients.
Conclusion
Aspirin has encouraging long-term chemo preventive benefits, particularly in ovarian and colorectal malignancies. However, the substantial bleeding hazards and unknown consequences in elderly persons outweigh its advantages. Before routinely prescribing aspirin usage for cancer prevention, a thorough risk-benefit analysis and customized dose regimens are necessary.
Zitieren
APA
S, S. M., Fathima, L., S, M., D, P., R, S., M, R., & Dhamodhar, D. (2026). Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence. International Journal of Drug Delivery Technology, 16(7s). https://doi.org/10.25258/ijddt.16.7s.22
Vancouver
S SM, Fathima L, S M, D P, R S, M R, et al. Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence. International Journal of Drug Delivery Technology. 2026;16(7s). doi:10.25258/ijddt.16.7s.22
BibTeX
@article{S2026,
author = {S, Sai Meera and Fathima, Lubna and S, Muthulakshmi and D, Prabu and R, Sindhu and M, Rajmohan and Dhamodhar, Dinesh},
title = {Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {7s},
doi = {10.25258/ijddt.16.7s.22}
}
EUVIMED